Highline Capital Management, L.P. Arcturus Therapeutics Holdings Inc. Transaction History

Highline Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$12.66 - $58.27 $712,808 - $3.28 Million	-56,304 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.31 - $18.26 $231,819 - $454,674	24,900 Added 79.29%	56,304 $765,000
Q4 2019 Feb 14, 2020	SELL	$8.93 - $12.41 $517,600 - $719,308	-57,962 Reduced 64.86%	31,404 $341,000
Q3 2019 Nov 14, 2019	SELL	$8.8 - $14.5 $1.13 Million - $1.86 Million	-128,500 Reduced 58.98%	89,366 $918,000
Q2 2019 Aug 14, 2019	BUY	$5.78 - $9.79 $1.26 Million - $2.13 Million	217,866 New	217,866 $2.06 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $449M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Highline Capital Management, L.P. with notifications on news.